[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] news worth sharing; Novolog approval for pumps

>Rapid-Acting NovoLog Insulin Approved for Use With External Insulin Pumps  

WASHINGTON (Reuters Health) Dec 26 - Novo Nordisk Pharmaceuticals reported on 
Wednesday that it has received a supplementary approval from the US Food and 
Drug Administration (FDA) allowing the use of its rapid-acting insulin analog 
NovoLog (insulin aspart [rDNA origin]) with external insulin pumps. The new 
approval makes NovoLog the first and only insulin analog to be indicated for 
use with the pumps, according to Novo Nordisk. NovoLog is indicated for 
control of hyperglycemia in adults with type II diabetes. The product was 
approved by the FDA in June and has been available in the US since September. 
It is sold in cartridges for use with Novo Nordisk's NovoPen and Innovo 
delivery devices and in vials for use with the external pumps or for syringe 
delivery. NovoLog, which has a rapid onset and relatively short duration, is 
usually used as part of a regimen that also includes intermediate or 
long-acting insulin. Novo Nordisk noted that it soon intends to launch a 
combined blood glucose monitoring and insulin dosing system called InDuo, 
which will be appropriate for use with NovoLog cartridges.  <

for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml